Author

Valentin Junet

Universitat Autònoma de BarcelonaORCID 0000-0002-6138-0612Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:batch correction / integration· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

José Manuel MasiD· 2 shared Albert Pujol· 1 shared Baldomero OlivaiD· 1 shared Beichen GaoiD· 1 shared Cristina Segú-VergésiD· 1 shared Guillem JorbaiD· 1 shared Jakub KucharczykiD· 1 shared Joaquim Aguirre‐PlansiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

José Manuel MasORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 23, 2025

Predicting TCR antigen specificity at proteome-scale with synthetic immune cells and machine learning

Kai‐Lin Hong, Beichen Gao, Lucas Stalder…·Sai T. Reddy

The paper presents a synthetic immune cell platform integrated with machine learning to predict TCR specificity to peptide-HLA antigens across the human proteome.

1 citation

humanproteomics

𝕏 PostBluesky

BioinformaticsBioinformaticsPeer-reviewedFeb 16, 2021

CuBlock: A cross-platform normalization method for gene-expression microarrays

Valentin Junet, Judith Farrés, José Manuel Mas, Xavier Daura

CuBlock normalizes gene-expression microarray data across platforms, effectively separating biological groups, outperforming existing methods in this task.

18 citations

bulk RNA-seqstatistical model

𝕏 PostBluesky

BioinformaticsPLoS ONEPeer-reviewedFeb 13, 2020

TPMS technology to infer biomarkers of macular degeneration prognosis in in silico simulated prototype-patients under the study of heart failure treatment with sacubitril and valsartan

Guillem Jorba, Joaquim Aguirre‐Plans, Valentin Junet…·Baldomero Oliva

The paper uses TPMS to model drug mechanisms and identify biomarkers linked to macular degeneration as an adverse effect of heart failure treatment with sacubitril/valsartan.

45 citations

humanstatistical model

𝕏 PostBluesky